Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Safety netting in routine primary care consultations: an observational study using video-recorded UK consultations.

Edwards PJ, Ridd MJ, Sanderson E, Barnes RK.

Br J Gen Pract. 2019 Nov 28;69(689):e878-e886. doi: 10.3399/bjgp19X706601. Print 2019 Dec.

2.

Development of a tool for coding safety-netting behaviours in primary care: a mixed-methods study using existing UK consultation recordings.

Edwards PJ, Ridd MJ, Sanderson E, Barnes RK.

Br J Gen Pract. 2019 Nov 28;69(689):e869-e877. doi: 10.3399/bjgp19X706589. Print 2019 Dec.

3.

Best emollients for eczema (BEE) - comparing four types of emollients in children with eczema: protocol for randomised trial and nested qualitative study.

Ridd MJ, Wells S, Edwards L, Santer M, MacNeill S, Sanderson E, Sutton E, Shaw ARG, Banks J, Garfield K, Roberts A, Barrett TJ, Baxter H, Taylor J, Lane JA, Hay AD, Williams HC, Thomas KS.

BMJ Open. 2019 Nov 6;9(11):e033387. doi: 10.1136/bmjopen-2019-033387.

4.

Which emollients are effective and acceptable for eczema in children?

Ridd MJ, Roberts A, Grindlay D, Williams HC.

BMJ. 2019 Oct 24;367:l5882. doi: 10.1136/bmj.l5882. Review. No abstract available.

PMID:
31649114
5.

TReatIng Urinary symptoms in Men in Primary Healthcare using non-pharmacological and non-surgical interventions (TRIUMPH) compared with usual care: study protocol for a cluster randomised controlled trial.

Frost J, Lane JA, Cotterill N, Fader M, Hackshaw-McGeagh L, Hashim H, Macaulay M, MacNeill SJ, Noble S, Rees J, Ridd MJ, Robles L, Taylor G, Taylor J, Drake MJ, Worthington J.

Trials. 2019 Sep 2;20(1):546. doi: 10.1186/s13063-019-3648-1.

6.

Symptom reporting, healthcare-seeking behaviour and antibiotic use for common infections: protocol for Bug Watch, a prospective community cohort study.

Smith CM, Conolly A, Fuller C, Hill S, Lorencatto F, Marcheselli F, Michie S, Mindell JS, Ridd MJ, Shallcross LJ, Tsakos G, Hayward A, Fragaszy EB.

BMJ Open. 2019 May 22;9(5):e028676. doi: 10.1136/bmjopen-2018-028676.

7.

TEST (Trial of Eczema allergy Screening Tests): protocol for feasibility randomised controlled trial of allergy tests in children with eczema, including economic scoping and nested qualitative study.

Ridd MJ, Edwards L, Santer M, Chalmers JR, Waddell L, Marriage D, Muller I, Roberts K, Garfield K, Coast J, Selman L, Clement C, Shaw ARG, Angier E, Blair PS, Turner NL, Taylor J, Kai J, Boyle RJ.

BMJ Open. 2019 May 9;9(5):e028428. doi: 10.1136/bmjopen-2018-028428.

8.

Beliefs and practices among adults with eczema and carers of children with eczema regarding the role of food allergy.

Chan J, Ridd MJ.

Clin Exp Dermatol. 2019 Oct;44(7):e235-e237. doi: 10.1111/ced.13955. Epub 2019 Mar 21.

PMID:
30834551
9.

Adverse Events from Emollient Use in Eczema: A Restricted Review of Published Data.

Bhanot A, Huntley A, Ridd MJ.

Dermatol Ther (Heidelb). 2019 Jun;9(2):193-208. doi: 10.1007/s13555-019-0284-3. Epub 2019 Feb 15. Review.

10.

Efficiency versus thoroughness in medication review: a qualitative interview study in UK primary care.

Duncan P, Cabral C, McCahon D, Guthrie B, Ridd MJ.

Br J Gen Pract. 2019 Mar;69(680):e190-e198. doi: 10.3399/bjgp19X701321. Epub 2019 Feb 11.

11.

Associations between physical activity and asthma, eczema and obesity in children aged 12-16: an observational cohort study.

Jago R, Salway RE, Ness AR, Shield JPH, Ridd MJ, Henderson AJ.

BMJ Open. 2019 Jan 20;9(1):e024858. doi: 10.1136/bmjopen-2018-024858.

12.

Adaption and validation of the Working Alliance Inventory for General Practice: qualitative review and cross-sectional surveys.

Sturgiss EA, Rieger E, Haesler E, Ridd MJ, Douglas K, Galvin SL.

Fam Pract. 2019 Jul 31;36(4):516-522. doi: 10.1093/fampra/cmy113.

13.

Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT.

Santer M, Rumsby K, Ridd MJ, Francis NA, Stuart B, Chorozoglou M, Roberts A, Liddiard L, Nollett C, Hooper J, Prude M, Wood W, Thomas-Jones E, Becque T, Thomas KS, Williams HC, Little P.

Health Technol Assess. 2018 Oct;22(57):1-116. doi: 10.3310/hta22570.

14.

Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema).

Stuart B, Rumsby K, Santer M, Ridd MJ, Francis NA, Chorozoglou M, Spreadbury C, Steele M, Nollett C, Liddiard L, Prude M, Hooper J, Thomas-Jones E, Roberts A, Thomas KS, Williams HC, Little P.

Trials. 2018 Oct 24;19(1):582. doi: 10.1186/s13063-018-2962-3.

15.

Emollient prescribing formularies in England and Wales: a cross-sectional study.

Chan JP, Boyd G, Quinn PA, Ridd MJ.

BMJ Open. 2018 Jun 12;8(6):e022009. doi: 10.1136/bmjopen-2018-022009.

16.

Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness.

Santer M, Ridd MJ, Francis NA, Stuart B, Rumsby K, Chorozoglou M, Becque T, Roberts A, Liddiard L, Nollett C, Hooper J, Prude M, Wood W, Thomas KS, Thomas-Jones E, Williams HC, Little P.

BMJ. 2018 May 3;361:k1332. doi: 10.1136/bmj.k1332.

17.

Comparison of patient (POEM), observer (EASI, SASSAD, TIS) and corneometry measures of emollient effectiveness in children with eczema: findings from the COMET feasibility trial.

Ridd MJ, Gaunt DM, Guy RH, Redmond NM, Garfield K, Hollinghurst S, Ball N, Shaw L, Purdy S, Metcalfe C.

Br J Dermatol. 2018 Aug;179(2):362-370. doi: 10.1111/bjd.16475. Epub 2018 Jun 7.

PMID:
29476542
18.

GP and parent dissonance about the assessment and treatment of childhood eczema in primary care: a qualitative study.

Powell K, Le Roux E, Banks J, Ridd MJ.

BMJ Open. 2018 Feb 15;8(2):e019633. doi: 10.1136/bmjopen-2017-019633.

19.

GPs' experiences of diagnosing and managing childhood eczema: a qualitative study in primary care.

Le Roux E, Powell K, Banks JP, Ridd MJ.

Br J Gen Pract. 2018 Feb;68(667):e73-e80. doi: 10.3399/bjgp18X694529. Epub 2018 Jan 15.

20.

Written action plans for children with long-term conditions: A systematic review and synthesis of qualitative data.

Waldecker A, Malpass A, King A, Ridd MJ.

Health Expect. 2018 Jun;21(3):585-596. doi: 10.1111/hex.12643. Epub 2017 Dec 9.

21.

Developing a written action plan for children with eczema: a qualitative study.

Powell K, Le Roux E, Banks JP, Ridd MJ.

Br J Gen Pract. 2018 Feb;68(667):e81-e89. doi: 10.3399/bjgp17X693617. Epub 2017 Dec 4.

22.

Impact of a deferred recruitment model in a randomised controlled trial in primary care (CREAM study).

Shepherd V, Thomas-Jones E, Ridd MJ, Hood K, Addison K, Francis NA.

Trials. 2017 Nov 10;18(1):533. doi: 10.1186/s13063-017-2284-x.

23.

Diagnosis, assessment, and treatment of childhood eczema in primary care: cross-sectional study.

Jacquet L, Gaunt DM, Garfield K, Ridd MJ.

BJGP Open. 2017 May 3;1(2):bjgpopen17X1000821. doi: 10.3399/bjgpopen17X100821.

24.

Systematic review of self-management interventions for people with eczema.

Ridd MJ, King AJL, Le Roux E, Waldecker A, Huntley AL.

Br J Dermatol. 2017 Sep;177(3):719-734. doi: 10.1111/bjd.15601. Epub 2017 Aug 2. Review.

25.

The 'One in a Million' study: creating a database of UK primary care consultations.

Jepson M, Salisbury C, Ridd MJ, Metcalfe C, Garside L, Barnes RK.

Br J Gen Pract. 2017 May;67(658):e345-e351. doi: 10.3399/bjgp17X690521. Epub 2017 Apr 10.

26.

Oral and Topical Antibiotics for Clinically Infected Eczema in Children: A Pragmatic Randomized Controlled Trial in Ambulatory Care.

Francis NA, Ridd MJ, Thomas-Jones E, Butler CC, Hood K, Shepherd V, Marwick CA, Huang C, Longo M, Wootton M, Sullivan F; CREAM Trial Management Group.

Ann Fam Med. 2017 Mar;15(2):124-130. doi: 10.1370/afm.2038.

27.

The management of acne in primary care.

Ridd MJ.

Br J Dermatol. 2017 Jan;176(1):1-2. doi: 10.1111/bjd.15169. No abstract available.

PMID:
28098382
28.

How do carers and children with eczema choose their emollient?

Ridd MJ, Santer M, Thomas KS, Roberts A, MacNeill SJ.

Clin Exp Dermatol. 2017 Mar;42(2):203. doi: 10.1111/ced.12982. Epub 2017 Jan 2. No abstract available.

PMID:
28044369
30.

Choice of Moisturiser for Eczema Treatment (COMET): feasibility study of a randomised controlled parallel group trial in children recruited from primary care.

Ridd MJ, Garfield K, Gaunt DM, Hollinghurst S, Redmond NM, Powell K, Wilson V, Guy RH, Ball N, Shaw L, Purdy S, Metcalfe C.

BMJ Open. 2016 Nov 16;6(11):e012021. doi: 10.1136/bmjopen-2016-012021.

31.

Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.

Barbarot S, Rogers NK, Abuabara K, Aubert H, Chalmers J, Flohr C, Hanifin J, Naldi L, Margolis DJ, Paul C, Ridd MJ, Schuttelaar MA, Simpson E, Tauber M, Volke A, Weidinger S, Wilkes SR, Wollenberg A, Thomas KS.

J Am Acad Dermatol. 2016 Nov;75(5):1038-1044. doi: 10.1016/j.jaad.2016.05.043. Epub 2016 Aug 10. Review.

PMID:
27522613
32.

Ineffective consultations for acne: what is important to patients?

Cowdell F, Eady EA, Layton AM, Levell NJ, Jones C, Ridd MJ.

Br J Dermatol. 2016 Oct;175(4):826-8. doi: 10.1111/bjd.14689. Epub 2016 Aug 11. No abstract available.

PMID:
27114267
33.

A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the ChildRen with Eczema, Antibiotic Management (CREAM) study.

Francis NA, Ridd MJ, Thomas-Jones E, Shepherd V, Butler CC, Hood K, Huang C, Addison K, Longo M, Marwick C, Wootton M, Howe R, Roberts A, Haq MI, Madhok V, Sullivan F; CREAM team.

Health Technol Assess. 2016 Mar;20(19):i-xxiv, 1-84. doi: 10.3310/hta20190.

34.

Bath additives for the treatment of childhood eczema (BATHE): protocol for multicentre parallel group randomised trial.

Santer M, Rumsby K, Ridd MJ, Francis NA, Stuart B, Chorozoglou M, Wood W, Roberts A, Thomas KS, Williams HC, Little P.

BMJ Open. 2015 Nov 1;5(10):e009575. doi: 10.1136/bmjopen-2015-009575.

35.

Choice of Moisturiser for Eczema Treatment (COMET): study protocol for a randomized controlled trial.

Ridd MJ, Redmond NM, Hollinghurst S, Ball N, Shaw L, Guy R, Wilson V, Metcalfe C, Purdy S.

Trials. 2015 Jul 15;16:304. doi: 10.1186/s13063-015-0830-y.

36.

Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the Clinical Practice Research Datalink.

Redaniel MT, Martin RM, Ridd MJ, Wade J, Jeffreys M.

PLoS One. 2015 May 1;10(5):e0126608. doi: 10.1371/journal.pone.0126608. eCollection 2015.

37.

Patient-doctor continuity and diagnosis of cancer: electronic medical records study in general practice.

Ridd MJ, Ferreira DL, Montgomery AA, Salisbury C, Hamilton W.

Br J Gen Pract. 2015 May;65(634):e305-11. doi: 10.3399/bjgp15X684829.

38.

Predictors of dizziness in older persons: a 10-year prospective cohort study in the community.

Maarsingh OR, Stam H, van de Ven PM, van Schoor NM, Ridd MJ, van der Wouden JC.

BMC Geriatr. 2014 Dec 15;14:133. doi: 10.1186/1471-2318-14-133.

39.

The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of eczema.

Batchelor JM, Ridd MJ, Clarke T, Ahmed A, Cox M, Crowe S, Howard M, Lawton S, McPhee M, Rani A, Ravenscroft JC, Roberts A, Thomas KS.

Br J Dermatol. 2013 Mar;168(3):577-82. doi: 10.1111/bjd.12040. Epub 2013 Jan 18.

PMID:
22963149
40.

Patient-doctor depth-of-relationship scale: development and validation.

Ridd MJ, Lewis G, Peters TJ, Salisbury C.

Ann Fam Med. 2011 Nov-Dec;9(6):538-45. doi: 10.1370/afm.1322.

41.

Professional experience guides opioid prescribing for chronic joint pain in primary care.

Gooberman-Hill R, Heathcote C, Reid CM, Horwood J, Beswick AD, Williams S, Ridd MJ.

Fam Pract. 2011 Feb;28(1):102-9. doi: 10.1093/fampra/cmq083. Epub 2010 Oct 20.

PMID:
20961966
42.

Five futures for academic medicine: "speed networking" may be one way forward.

Ridd MJ, Shaw AR.

BMJ. 2005 Sep 24;331(7518):695. No abstract available.

43.

Ginkgo biloba abolishes aggression in mice lacking MAO A.

Shih JC, Chen K, Ridd MJ, Seif I.

Antioxid Redox Signal. 2000 Fall;2(3):467-71.

PMID:
11229360
44.

The effects of copper on the microbial community of a coral reef sponge.

Webster NS, Webb RI, Ridd MJ, Hill RT, Negri AP.

Environ Microbiol. 2001 Jan;3(1):19-31.

PMID:
11225720
45.

Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A.

Shih JC, Ridd MJ, Chen K, Meehan WP, Kung MP, Seif I, De Maeyer E.

Brain Res. 1999 Jul 24;835(2):104-12.

PMID:
10415365
46.

Role of MAO A and B in neurotransmitter metabolism and behavior.

Shih JC, Chen K, Ridd MJ.

Pol J Pharmacol. 1999 Jan-Feb;51(1):25-9. Review.

PMID:
10389141
47.

Monoamine oxidase: from genes to behavior.

Shih JC, Chen K, Ridd MJ.

Annu Rev Neurosci. 1999;22:197-217. Review.

48.

The effect of acute kainic acid treatment on mu-opioid receptors in rat brain.

Ridd MJ, Fosbraey P, Kitchen I.

Brain Res. 1998 Dec 14;814(1-2):26-33.

PMID:
9838030
49.

The effect of acute kainic acid treatment on dopamine D2 receptors in rat brain.

Ridd MJ, Kitchen I, Fosbraey P.

Neurosci Res. 1998 Mar;30(3):201-11.

PMID:
9593330
50.

The disposition and placental transfer of diazepam in cesarean section.

Ridd MJ, Brown KF, Nation RL, Collier CB.

Clin Pharmacol Ther. 1989 May;45(5):506-12.

PMID:
2721106

Supplemental Content

Support Center